Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability

December 15, 2020

The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Click PLAY to watch the video abstract.


Click here to watch the full supplement infographic.


Click here to read full article to this video abstract.